Shanghai MicroPort Endovascular MedTech Co., Ltd.

Shanghai Stock Exchange 688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd. Operating Income for the year ending December 31, 2023: USD 80.83 M

Shanghai MicroPort Endovascular MedTech Co., Ltd. Operating Income is USD 80.83 M for the year ending December 31, 2023, a 34.33% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Shanghai MicroPort Endovascular MedTech Co., Ltd. Operating Income for the year ending December 31, 2022 was USD 60.17 M, a 5.39% change year over year.
Shanghai MicroPort Endovascular MedTech Co., Ltd. Operating Income for the year ending December 31, 2021 was USD 57.09 M, a 49.11% change year over year.
Shanghai MicroPort Endovascular MedTech Co., Ltd. Operating Income for the year ending December 31, 2020 was USD 38.29 M, a 62.32% change year over year.
Shanghai MicroPort Endovascular MedTech Co., Ltd. Operating Income for the year ending December 31, 2019 was USD 23.59 M, a 54.73% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Shanghai Stock Exchange: 688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

CEO	Mr. Qing Zhu
IPO Date	July 22, 2019
Location	China
Headquarters	Building 1
Employees	908
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Shanghai MicroPort Endovascular MedTech Co., Ltd. develops, manufactures, and sells technologies and products in the healthcare business. The company primarily offers solutions for aortic and peripheral diseases. Its products include TAA and AAA stent graft systems, balloon inflation catheters, and PTA balloon dilatation catheters. The company was founded in 2012 and is based in Shanghai, the People's Republic of China. Shanghai MicroPort Endovascular MedTech Co., Ltd. is a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd.

Key trends

Past 5 years